Livanova PLC has announced the launch and enrollment of the first patient for its observational post-market study to assess the effectiveness of its Vagus Nerve Stimulation Therapy. The study will assess the short, medium and long term impact of ‘VNS Therapy’ on those suffering from treatment resistant depression. Read the article here.
The Business Insider reports that there are plenty of people out there with chronic pain and low energy and who walk around feeling terrible all the time. But it never occurs to them that they might be depressed. And our healthcare system doesn’t do a good job of connecting them with the screening or treatment that could help them feel better. Read the complete article.